Literature DB >> 15644626

Ethnic differences in cerebral venous thrombosis.

Erica Cristina Sá de Camargo1, Ayrton Roberto Massaro, Luiz Alberto Bacheschi, Elbio Antônio D'Amico, Paula Ribeiro Villaça, Rogério Pastore Bassitt, Sandra Fátima Gualandro, Israel Bendit, Milberto Scaff.   

Abstract

BACKGROUND: Cerebral venous thromboses (CVT) with distinct clinical presentations have been shown worldwide. However, there is little information regarding race-ethnic differences in this disease.
METHODS: We prospectively studied 50 CVT patients from Brazil, comparing clinical and laboratory data among white (W) and African-Brazilian (AB) patients.
RESULTS: Seventy percent of the patients were female, 26 W and 23 AB, mean age 34.7 years. Multiple sinus CVT, deep CVT and worse outcome were significantly more frequent in AB than in W patients. There was a trend towards a higher frequency of factor V Leiden and prothrombin mutation in W than in AB, and of protein C deficiency in AB.
CONCLUSIONS: CVT was more severe in AB patients than in W patients. Race-ethnic differences may account for the heterogeneous distribution of inherited thrombophilia in this series. Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2005        PMID: 15644626     DOI: 10.1159/000083247

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  2 in total

1.  Analyzing the Effects of Demographic Differences on Patient Outcomes Following Non-pyogenic Intracranial Venous Thrombosis.

Authors:  Kevin F Labagnara; Jessie Birnbaum; Santiago R Unda; David J Altschul
Journal:  Cureus       Date:  2021-11-19

2.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.